VALRUBICIN J Code: J9357

Drug & Product Overview

HCPCS Descriptor Injection, valrubicin, intravesical, 200 mg

HCPCS Added Date January 1, 2000

Manufacturer Multiple Manufacturers

Route of Administration Intravesical

Generic Status Multi-Source; Generic

Dosage Type Single-Dose

Dosage Form Solution, Concentrate

About VALRUBICIN

Valrubicin is a medication aligned to the HCPCS J Code: J9357 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the intravesical route and manufactured by multiple companies.

According to CMS Drug Use Information: Valrubicin is used to treat bladder cancer. The usual treatment for bladder cancer is surgery. However, if you and your doctor decide that the risk of surgery is greater than its benefit or that surgery may be delayed, this medication may be used as part of your treatment. This medication belongs to a class of drugs known as anthracyclines and works by slowing or stopping the growth of cancer cells. This medication may not cure your cancer. Delaying surgery could lead to a more serious illness (metastatic cancer). Discuss the risks and benefits of this medication with your doctor.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
24201-0101-04	Valrubicin Intravesical Solution	Hikma Pharmaceuticals USA Inc.	4	200 MG / 5 ML
67979-0001-01	Valstar	Endo USA, Inc.	4	200 MG / 5 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

VALRUBICIN Pricing & Reimbursement

J9357 Private Payer Reimbursement

$1,359.84 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

VALRUBICIN CPT Administration Codes

CPT Code	Description
51720	Bladder instillation of anticarcinogenic agent, including retention time

JW / JZ modifiers apply

CMS has identified Valrubicin (J9357) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

VALRUBICIN Medically Unlikely Edits (MUE)

The most billing units of J9357 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 200 mg.

Practitioner Office & Hospital Outpatient

4 units / day

= 800 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

VALRUBICIN Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

BCG-refractory carcinoma in situ (CIS) of the urinary bladder

Frequently Asked Questions

Is there an available Valrubicin billing and coding guide?

We have not yet identified a manufacturer source of Valrubicin billing and coding information.

Are there any available Valrubicin patient assistance programs?

Our team did not identify a source for Valrubicin patient assistance information. Please reach out to our team if you feel that this is a mistake.

Where can I find Valrubicin prescribing information?

VALRUBICIN prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date. Visit Here →

Where can I find Valrubicin side effect information?

Our team has not yet identified a source of side effects information for VALRUBICIN. Please check back in a few weeks.

Does billing VALRUBICIN require JZ/JW wastage modifiers?

CMS has identified VALRUBICIN(J9357) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.